Sonova Holding AG (SONVF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Sonova Holding AG (SONVF) trades at $257.67 with AI Score 52/100 (Grade B). Sonova Holding AG is a global leader in hearing care solutions, designing, manufacturing, and distributing hearing instruments and cochlear implants. Market cap: $15.31B, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for SONVF: SONVF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SONVF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
SONVF: 2/7 perspectives are bullish. Dominant signal: Ken Griffin bearish.
How is this calculated? →Sonova Holding AG (SONVF) Healthcare & Pipeline Overview
Sonova Holding AG, a Swiss-based company, is a global leader in hearing care solutions, offering a comprehensive portfolio of hearing instruments, cochlear implants, and audiological services under brands like Phonak and Unitron. With a wide geographic reach and a focus on innovation, Sonova addresses the diverse needs of hearing-impaired individuals.
What Is the Investment Thesis for SONVF?
Sonova Holding AG presents a compelling investment case driven by the growing global demand for hearing care solutions. The company's strong market position, diversified product portfolio, and extensive distribution network provide a solid foundation for future growth. With a market capitalization of $15.31B and a P/E ratio of 23.2, Sonova demonstrates financial stability. Key growth catalysts include the aging global population, increasing awareness of hearing loss, and technological advancements in hearing aid technology. A potential risk factor is the competitive landscape, with companies like BMXMF vying for market share. Sonova's commitment to innovation and its focus on expanding its audiological care services network are expected to drive long-term value creation.
Based on FMP financials and quantitative analysis
SONVF Key Highlights
- Market Cap of $15.31B reflects Sonova's significant presence in the hearing care industry.
- P/E ratio of 23.2 indicates investor confidence in Sonova's earnings potential.
- Profit Margin of 13.5% demonstrates efficient operations and profitability.
- Gross Margin of 70.5% showcases Sonova's ability to maintain strong pricing power.
- Dividend Yield of 2.32% provides an attractive income stream for investors.
Who Are SONVF's Competitors?
SONVF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BMXMF bioMérieux S.A. | $77.00 | -1.19% | $9.09B | 52 |
| CHEOF Cochlear Limited | $81.42 | +0.00% | $5.32B | 54 |
| CHEOY Cochlear Limited | $44.28 | +5.69% | $5.79B | 54 |
| FMCQF Fresenius Medical Care AG & Co. KGaA | $43.01 | -4.78% | $11.55B | 46 |
| GIKLY Grifols, S.A. | $4.77 | -6.47% | $12.54B | 48 |
| DCTH Delcath Systems, Inc. | $13.61 | +3.11% | $469.84M | 73 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $0.20 | +3.40% | $18.68M | 73 |
| SSII SS Innovations International, Inc. | $3.76 | -0.53% | $752.49M | 72 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SONVF's Key Strengths?
- Strong brand portfolio (Phonak, Unitron, Hansaton).
- Extensive global distribution network.
- Technological leadership in hearing care solutions.
- Diversified product offerings (hearing instruments, cochlear implants, wireless communication devices).
What Are SONVF's Weaknesses?
- Exposure to currency fluctuations.
- Dependence on independent distributors.
- High research and development costs.
- Competition from established players.
What Could Drive SONVF Stock Higher?
- Aging global population driving increased demand for hearing care solutions.
- Technological advancements in hearing aid technology improving performance and user experience.
- Potential regulatory approvals for new hearing care products.
- Expansion of audiological care services network in key markets.
- Strategic partnerships with healthcare providers and technology companies.
What Are the Key Risks for SONVF?
- Inconsistent delivery — missed Wall Street EPS estimates in 4 of the last 8 reported quarters.
- Increased competition from low-cost manufacturers.
- Changes in government regulations affecting the hearing care industry.
- Economic downturns impacting consumer spending on hearing care solutions.
- Technological obsolescence rendering existing products outdated.
- Currency fluctuations impacting financial performance.
What Are the Growth Opportunities for SONVF?
- Expansion of Audiological Care Services Network: Sonova has the opportunity to expand its network of audiological care service centers. By increasing its presence in key markets and offering comprehensive hearing care services, Sonova can attract new customers and strengthen its relationships with existing ones. This expansion can be achieved through acquisitions, partnerships, and the opening of new clinics. The global audiology services market is estimated to reach $15 billion by 2028, providing a significant growth opportunity for Sonova.
- Technological Innovation: Sonova can continue to invest in research and development to develop innovative hearing care solutions. This includes developing advanced hearing aids with improved sound quality, noise reduction, and wireless connectivity. Sonova can also explore new technologies such as artificial intelligence and machine learning to enhance the performance of its hearing aids and provide personalized hearing care solutions. The market for advanced hearing aids is expected to grow rapidly in the coming years, driven by the demand for improved hearing performance and user experience.
- Geographic Expansion: Sonova can expand its presence in emerging markets such as China, India, and Brazil. These markets have a large and growing population of people with hearing loss, and there is a significant unmet need for hearing care solutions. Sonova can enter these markets through partnerships, acquisitions, and the establishment of new distribution networks. The emerging markets offer significant growth potential for Sonova, as the demand for hearing care solutions is expected to increase rapidly in the coming years.
- Strategic Partnerships: Sonova can form strategic partnerships with other companies in the healthcare industry. This includes partnerships with hospitals, clinics, and other healthcare providers. These partnerships can help Sonova to reach new customers and expand its distribution network. Sonova can also partner with technology companies to develop innovative hearing care solutions. Strategic partnerships can provide Sonova with access to new markets, technologies, and expertise.
- Direct-to-Consumer Sales: Sonova can expand its direct-to-consumer sales channels. This includes selling hearing aids and other hearing care products online and through mail order. Direct-to-consumer sales can help Sonova to reach new customers and reduce its reliance on traditional distribution channels. The direct-to-consumer market for hearing aids is growing rapidly, driven by the increasing availability of online resources and the convenience of purchasing hearing aids from home.
What Opportunities Does SONVF Have?
- Expansion in emerging markets.
- Growth in the direct-to-consumer market.
- Development of new hearing care technologies.
- Strategic partnerships with healthcare providers.
What Threats Does SONVF Face?
- Increased competition from low-cost manufacturers.
- Changes in government regulations.
- Economic downturns.
- Technological obsolescence.
What Are SONVF's Competitive Advantages?
- Strong brand recognition with brands like Phonak and Unitron.
- Extensive distribution network with approximately 3,600 stores and clinics.
- Technological innovation in hearing care solutions.
- Established relationships with independent distributors.
What Does SONVF Do?
Founded in 1947 and headquartered in Stäfa, Switzerland, Sonova Holding AG has evolved into a global leader in the hearing care industry. Originally known as Phonak Holding AG, the company changed its name to Sonova Holding AG in August 2007. Sonova designs, develops, manufactures, and distributes a wide range of hearing care solutions for adults and children. These solutions include hearing instruments, cochlear implants, and wireless communication devices. The company operates through two primary segments: Hearing Instruments and Cochlear Implants. Sonova's product portfolio includes well-known brands such as Phonak, Unitron, Hansaton, Advanced Bionics, and Sennheiser (consumer hearing products). The company provides audiological care services through a network of approximately 3,600 stores and clinics operating under brands like AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton. Sonova's geographic reach spans the United States, Europe, the Middle East, Africa, and the Asia Pacific region. The company sells its products through independent distributors and its own network of hearing care centers.
What Products and Services Does SONVF Offer?
- Designs, develops, and manufactures hearing instruments for adults and children.
- Produces and distributes cochlear implants for individuals with severe hearing loss.
- Offers wireless communication products to enhance hearing aid functionality.
- Provides rechargeable hearing aids for user convenience.
- Manufactures wireless headsets, speech-enhanced hearables, and audiophile headphones.
- Offers audiological care services through a network of stores and clinics.
- Sells hearing instruments under the Phonak, Unitron, and Hansaton brand names.
- Provides cochlear implants under the Advanced Bionics brand.
How Does SONVF Make Money?
- Develops and manufactures hearing care solutions.
- Sells products through independent distributors and a network of stores and clinics.
- Provides audiological care services to customers.
- Generates revenue from the sale of hearing instruments, cochlear implants, and wireless communication devices.
What Industry Does SONVF Operate In?
Sonova Holding AG operates in the medical devices industry, specifically within the hearing care solutions market. This market is driven by factors such as the aging global population, increasing awareness of hearing loss, and technological advancements in hearing aid technology. The competitive landscape includes companies like BMXMF, CHEOF, CHEOY, FMCQF, and GIKLY. Sonova's strong brand recognition, extensive distribution network, and focus on innovation position it as a key player in this growing market. The industry is expected to continue to grow in the coming years, driven by the increasing prevalence of hearing loss and the demand for advanced hearing care solutions.
Who Are SONVF's Key Customers?
- Adults and children with hearing loss.
- Individuals seeking wireless communication products.
- Audiologists and hearing care professionals.
- Hospitals and clinics providing hearing care services.
Company Profile
Sonova Holding AG operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Stäfa, CH. The company is led by CEO Eric Bernard. SONVF has traded publicly since 2007.
Sonova Holding AG Financial Trajectory
Sonova Holding AG (SONVF) reported $1.79B in revenue for Q1 2026, a decline of 1.0% compared to the prior quarter. The company recorded net income of $349.5M, with diluted EPS of $5.79. Revenue has contracted over three consecutive quarters, which investors in this large-cap Healthcare stock should monitor closely. Across the four most recent quarters, SONVF averaged $4.50 in diluted EPS.
How Sonova Holding AG Is Valued
Sonova Holding AG carries a market capitalization of $15.31B, placing it in the large-cap category. Relative to its peer group, SONVF's quantitative score of 52/100 is roughly in line with the peer average of 51/100.
ROE 21%Key Financial Metrics
Return on equity for Sonova Holding AG stands at 21.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 9.5%, showing how much profit it generates from its asset base. SONVF trades at a trailing price-to-earnings ratio of 23.25, roughly in line with the Healthcare sector average of ~23x. Its free cash flow yield is 5.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.75 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 4.5%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 7/9Financial Health
Sonova Holding AG's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 5.45 places it in the safe zone, indicating low near-term bankruptcy risk.
3/8 beatsEarnings Track Record
Sonova Holding AG has missed Wall Street's EPS estimate in 4 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 9.8% above estimates on average.
FY2026 estForward Outlook
Wall Street analysts project Sonova Holding AG revenue of about $3.73B for fiscal 2026, with EPS near $9.58. The estimate reflects 17 contributing analysts.
SONVF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Sonova's growth potential, indicating that executives believe in the company's future prospects.
- Community sentiment has shifted positively as investors discuss the company's innovative hearing solutions and expanding market presence.
- Analysts have highlighted Sonova's strong brand reputation, which is crucial in the competitive healthcare sector, bolstering investor confidence.
- The company's commitment to sustainability and technological advancements resonates well with socially conscious investors, enhancing its appeal.
Bear Case
- Despite positive sentiment, some community members express concerns about potential market saturation in the hearing aid sector, which could limit growth.
- Recent discussions indicate anxiety around supply chain challenges that might impact production efficiency and delivery timelines.
- There are worries about regulatory changes affecting the healthcare industry, which could pose risks to Sonova's business operations.
- Market perception remains cautious due to broader economic uncertainties that could impact consumer spending on healthcare products.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $1.79B | $349M | $5.79 |
| Q3 2025 | $1.81B | $188M | $3.16 |
| Q1 2025 | $2.03B | $332M | $5.55 |
| Q3 2024 | $1.83B | $209M | $3.49 |
Based on FMP financials and quantitative analysis
SONVF Latest News
-
GMED vs. SONVY: Which Stock Is the Better Value Option?
Yahoo! Finance: SONVF News · May 20, 2026
-
Sonova Holding AG (SONVY) Q4 2026 Earnings Call Transcript
seekingalpha.com · May 18, 2026
SONVF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SONVF.
Price Targets
Wall Street price target analysis for SONVF.
SONVF MoonshotScore
What does this score mean?
The MoonshotScore rates SONVF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Eric Bernard
CEO
Eric Bernard serves as the CEO of Sonova Holding AG, leading a global workforce of over 18,500 employees. His career spans various leadership roles within the healthcare and technology sectors. He brings extensive experience in strategic planning, operational excellence, and market expansion. His expertise is in driving innovation and growth in the medical device industry, with a focus on improving the lives of people with hearing loss.
Track Record: Under Eric Bernard's leadership, Sonova has continued to strengthen its market position and expand its global reach. He has overseen the launch of innovative hearing care solutions and the expansion of the company's audiological care services network. His strategic decisions have contributed to Sonova's financial performance and its commitment to providing high-quality hearing care to people around the world.
SONVF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Sonova Holding AG (SONVF) may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited information available to investors, and trading activity can be sporadic. Investing in OTC Other stocks carries a higher degree of risk compared to stocks listed on major exchanges like the NYSE or NASDAQ due to the potential for less transparency and regulatory oversight.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases information asymmetry.
- Lower trading volume can lead to price volatility.
- Potential for manipulation due to less regulatory oversight.
- Higher bid-ask spreads increase transaction costs.
- Delays in trade execution due to limited market makers.
- Verify the company's registration and legal standing.
- Obtain and review available financial statements.
- Assess the company's management team and track record.
- Research the company's industry and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal issues.
- Established history as Sonova Holding AG, founded in 1947.
- Global operations in multiple regions.
- Presence in the hearing care industry with recognized brands.
- Employing over 18,554 employees.
- Trades on the SIX Swiss Exchange.
Common Questions About SONVF (Healthcare)
What does Sonova Holding AG do?
Sonova Holding AG is a global leader in the hearing care industry, focused on designing, developing, manufacturing, and distributing hearing solutions. The company operates through two segments: Hearing Instruments and Cochlear Implants. Sonova offers a comprehensive portfolio of hearing aids, cochlear implants, and wireless communication devices under brands like Phonak, Unitron, and Advanced Bionics. Additionally, Sonova provides audiological care services through a network of stores and clinics, offering comprehensive hearing assessments, fitting, and aftercare services. The company's products and services cater to individuals of all ages with varying degrees of hearing loss.
What do analysts say about SONVF stock?
Analyst coverage of SONVF stock is limited due to its OTC listing. However, considering Sonova's financial performance, market position, and growth prospects, analysts generally view the company favorably. Key valuation metrics include the P/E ratio of 23.2 and the dividend yield of 2.32%. Growth considerations include the aging global population, increasing awareness of hearing loss, and technological advancements in hearing aid technology. Investors should conduct their own due diligence and consider their individual investment objectives before investing in SONVF stock.
What are the main risks for SONVF?
Sonova Holding AG faces several risks, including increased competition from low-cost manufacturers, changes in government regulations, economic downturns, and technological obsolescence. The company is also exposed to currency fluctuations, as it operates in multiple countries. Additionally, Sonova's reliance on independent distributors could pose a risk if these distributors fail to perform adequately. Investors should carefully consider these risks before investing in SONVF stock. The OTC listing also carries additional risks related to liquidity and transparency.
What are the key factors to evaluate for SONVF?
Sonova Holding AG (SONVF) holds an AI score of 52/100 (moderate). P/E: 23.2x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does SONVF data refresh on this page?
SONVF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven SONVF's recent stock price performance?
Sonova Holding AG (SONVF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand portfolio (Phonak, Unitron, Hansaton). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SONVF overvalued or undervalued right now?
Sonova Holding AG (SONVF) trades at 23.2x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying SONVF?
Before investing in Sonova Holding AG (SONVF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data may be limited or delayed.
- AI analysis pending for SONVF.